ArticleAmerican journal of respiratory and critical care medicine2019
Moving toward Tuberculosis Elimination. Critical Issues for Research in Diagnostics and Therapeutics for Tuberculosis Infection.
Abstract read
In one paragraph
Article in American journal of respiratory and critical care medicine, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 1 of them a synthesis that pooled it.
0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 1 pooled it
2.9field-weighted citation impact, top 8% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
15 citing papers in PubMed, 1 synthesis or guideline pooled it, 33 citations in OpenAlex.
- Diagnostic Accuracy of T-SPOT.TB Assay for Tuberculous Meningitis: An Updated Meta-Analysis.Frontiers in neurology · 2020Pooled it
- Unexpected detection of Mycobacterium tuberculosis DNA in US-born patients in putative association with clinical syndromes.Nature communications · 2026Observational
- Persistently high plasma procalcitonin levels despite successful treatment of tuberculous pleuritis and tuberculous lymphadenitis patients.Scientific reports · 2024Article
- Article
- Predictors for False-Negative Interferon-Gamma Release Assay Results in Hemodialysis Patients with Latent Tuberculosis Infection.Diagnostics (Basel, Switzerland) · 2022Article
- Cascade Immune Mechanisms of Protection against Mycobacterium tuberculosis (IMPAc-TB): study protocol for the Household Contact Study in the Western Cape, South Africa.BMC infectious diseases · 2022Article
- Uncovering the Mast Cell Response toFrontiers in immunology · 2022Review
- New Diagnostics to Infer Risk in Tuberculosis: Is the Term "Latent Tuberculosis Infection" Obsolete?American journal of respiratory and critical care medicine · 2021Article
- Combination of prealbumin and tuberculosis-specific antigen/phytohemagglutinin ratio for discriminating active tuberculosis from latent tuberculosis infection.International journal of clinical practice · 2021Article
- Toward patient-centered tuberculosis preventive treatment: preferences for regimens and formulations in Lima, Peru.BMC public health · 2021Article
- Lymphocyte Non-Specific Function Detection Facilitating the Stratification ofFrontiers in immunology · 2021Article
- Lymphocyte-Related Immunological Indicators for StratifyingFrontiers in immunology · 2021Article
- Risk-benefit analysis of tuberculosis infection testing for household contact management in high-burden countries: a mathematical modelling study.The Lancet. Global health · 2020Article
- Validation of Differentially Expressed Immune Biomarkers in Latent and Active Tuberculosis by Real-Time PCR.Frontiers in immunology · 2020Article
- Phenazine Antibiotic-Inspired Discovery of Bacterial Biofilm-Eradicating Agents.Chembiochem : a European journal of chemical biology · 2019Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
32 authors at 20 institutions in 8 countries.
Salmaan Keshavjee1 Harvard Medical School, Boston, Massachusetts.ORCID 0000-0002-6967-3305
Farhana Amanullah3 The Indus Hospital, Karachi, Pakistan.
Adithya Cattamanchi4 University of California San Francisco, Zuckerberg San Francisco General Hospital, San Francisco, California.
Richard Chaisson5 Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland.
Karen M Dobos6 Colorado State University, Fort Collins, Colorado.
Gregory J Fox7 University of Sydney, Sydney, New South Wales, Australia.
Howard E Gendelman8 University of Nebraska Medical Center, Omaha, Nebraska.
Richard Gordon9 South African Medical Research Council, Cape Town, Western Cape, South Africa.
Anneke Hesseling10 Desmond Tutu TB Centre and.
Hoi Le Van11 National Lung Hospital, Hanoi, Vietnam.
Beate Kampmann13 London School of Hygiene and Tropical Medicine, London, United Kingdom.
Bavesh Kana14 University of Witwatersrand, National Health Laboratory Service, Johannesburg, South Africa.
Gopal Khuller16 Postgraduate Institute of Medical Education and Research, Chandigarh, India.
David M Lewinsohn17 Oregon Health & Science University, Portland, Oregon.
Deborah A Lewinsohn17 Oregon Health & Science University, Portland, Oregon.
Philiana Ling Lin19 University of Pittsburgh, School of Medicine, Pittsburgh, Pennsylvania.
Lenette Lin Lu20 Massachusetts General Hospital, Boston, Massachusetts.
Gary Maartens21 Division of Clinical Pharmacology, Department of Medicine, University of Cape Town, Cape Town, South Africa.
Andrew Owen22 University of Liverpool, Liverpool, England.
Marina Protopopova23 Division of AIDS, National Institute of Allergy and Infectious Diseases, NIH, Department of Health and Human Services, Rockville, Maryland.
Jyothi Rengarajan24 Emory University School of Medicine, Atlanta, Georgia.
Eric Rubin25 Harvard T. H. Chan School of Public Health, Boston, Massachusetts.
Padmini Salgame26 Rutgers University, New Brunswick, New Jersey.
Erwin Schurr27 McGill University, Montreal, Quebec, Canada.
James A Seddon13 London School of Hygiene and Tropical Medicine, London, United Kingdom.
Susan Swindells8 University of Nebraska Medical Center, Omaha, Nebraska.
David M Tobin28 Duke University School of Medicine, Durham, North Carolina; and.
Zarir Udwadia29 Hinduja Hospital & Research Center, Mumbai, India.
Gerhard Walzl30 Division of Molecular Biology and Human Genetics, Stellenbosch University, Cape Town, South Africa.
Sudha Srinivasan23 Division of AIDS, National Institute of Allergy and Infectious Diseases, NIH, Department of Health and Human Services, Rockville, Maryland.
Roxana Rustomjee23 Division of AIDS, National Institute of Allergy and Infectious Diseases, NIH, Department of Health and Human Services, Rockville, Maryland.
Payam Nahid4 University of California San Francisco, Zuckerberg San Francisco General Hospital, San Francisco, California.
National Institute of Allergy and Infectious Diseases · USHarvard University · USLondon School of Hygiene & Tropical Medicine · GBNational Health Laboratory Service · ZAOregon Health & Science University · USSan Francisco General Hospital · USUniversity of Nebraska Medical Center · USColorado State University · USDesmond Tutu HIV Foundation · ZADuke University · USEmory University · USHanoi Lung Hospital · VNIndus Hospital · PKJohns Hopkins University · USMassachusetts General Hospital · USMcGill University · CAP. D. Hinduja Hospital and Medical Research Centre · INPost Graduate Institute of Medical Education and Research · INRutgers, The State University of New Jersey · USSouth African Medical Research Council · ZA
Funding
Yerkes National Primate Research Center Role of type-I IFN in regulating COVID-19 induced inflammation and pathogenesisP51OD011132 · OD · EMORY UNIVERSITY · PI Joon Sup Lee · 2012 to 2026
$167.0MVirology and Molecular Biomarkers CoreP30AI050409 · NIAID · EMORY UNIVERSITY · PI Carlos del Rio · 2002 to 2026
$74.0MVaccine Response and Immunotherapeutics SWGP30AI094189 · NIAID · JOHNS HOPKINS UNIVERSITY · PI Richard E. Chaisson · 2012 to 2026
$67.0MRole of antigen-specific T cell responses in the control of TBU19AI111211 · NIAID · EMORY UNIVERSITY · PI BLUMBERG, HENRY M, ERNST, JOEL D. · 2014 to 2020
$20.1MPharmacokinetics and Drug-Drug InteractionsP01DA028555 · NIDA · UNIVERSITY OF NEBRASKA MEDICAL CENTER · PI ALNOUTI, YAZEN · 2010 to 2019
$16.8MNeuroprotective Immunity and HIV DementiaR01NS034239 · NINDS · UNIVERSITY OF NEBRASKA MEDICAL CENTER · PI Howard E Gendelman, R Lee Mosley · 1995 to 2026
$12.3MThe Long-Acting/Extended Release Antiretroviral Resource Program (LEAP)R24AI118397 · NIAID · JOHNS HOPKINS UNIVERSITY · PI Charles W. Flexner · 2015 to 2026
$9.4MTB Surrogate Markers for Assessing Reponse to Treatment (TB SMART Study)R01AI104589 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI NAHID, PAYAM, SIGAL, GEORGE B · 2013 to 2017
$6.2MMacrophage Reprogramming During Granuloma Formation in the ZebrafishR01AI130236 · NIAID · DUKE UNIVERSITY · PI David M. Tobin · 2017 to 2026
$4.5MGenetic dissection of angiogenesis in the tuberculous granulomaR01AI125517 · NIAID · DUKE UNIVERSITY · PI David M. Tobin · 2017 to 2026
$4.4MPerturbation of antigen-specific T cell responses in latent TB/SIV co-infectionR01AI111943 · NIAID · TULANE UNIVERSITY OF LOUISIANA · PI KAUSHAL, DEEPAK, RENGARAJAN, JYOTHI · 2015 to 2019
$3.9MImpact of concurrent HIV and latent TB therapies on Mtb-specific immune function-Diversity SupplementR01AI123047 · NIAID · TULANE UNIVERSITY OF LOUISIANA · PI KAUSHAL, DEEPAK, RENGARAJAN, JYOTHI · 2017 to 2020
$3.9MDepartment of Health SRF-2009-02-07Medical Research Council MC_EX_MR/K011944/1Medical Research Council MC_EX_MR/P024270/1Medical Research Council MC_UP_A900_1122Medical Research Council MC_UU_00026/2Medical Research Council MR/M007340/1Medical Research Council MR/R007942/1NIAID NIH HHS HHSN272201000001GNIAID NIH HHS HHSN272201600001CNIAID NIH HHS HHSN272201600001GNIAID NIH HHS P30 AI050409NIAID NIH HHS P30 AI094189NIAID NIH HHS R01 AI104589NIAID NIH HHS R01 AI111943NIAID NIH HHS R01 AI123047NIAID NIH HHS R01 AI125517NIAID NIH HHS R01 AI127715NIAID NIH HHS R01 AI130236NIAID NIH HHS R24 AI118397NIAID NIH HHS U19 AI111211NIDA NIH HHS P01 DA028555NIH HHS P51 OD011132NINDS NIH HHS R01 NS034239
Abstract
PubMed holds no abstract for this paper.
Indexed as
Antitubercular AgentsBiomedical ResearchDisease EradicationDisease ProgressionEpidemicsHealth PrioritiesHumansLatent TuberculosisTuberculosis, PulmonaryAntitubercular Agents
Identifiers
What OpenQuestion holds
Textmetadata
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.